Rehmani A, Banaee T, Alwan S, Urias E, Lyons L, El-Annan J
Middle East Afr J Ophthalmol. 2024; 30(3):141-148.
PMID: 39444996
PMC: 11495293.
DOI: 10.4103/meajo.meajo_17_22.
Munk M, Ceklic L, Stillenmunkes R, Chaudhary V, Waheed N, Chhablani J
Diagnostics (Basel). 2024; 14(17).
PMID: 39272767
PMC: 11394301.
DOI: 10.3390/diagnostics14171983.
Lim S, Gan S, Ong H, Ngeow Y
Biochem Biophys Rep. 2024; 39:101814.
PMID: 39263317
PMC: 11387214.
DOI: 10.1016/j.bbrep.2024.101814.
Sheng X, Zhang C, Zhao J, Xu J, Zhang P, Ding Q
Cell Biosci. 2024; 14(1):85.
PMID: 38937783
PMC: 11212265.
DOI: 10.1186/s13578-024-01269-7.
Koirala A, Marshak-Rothstein A, Ksander B, Gregory-Ksander M
Res Sq. 2024; .
PMID: 38766158
PMC: 11100875.
DOI: 10.21203/rs.3.rs-4331250/v1.
Comparison of the cytokines levels in aqueous humor in vitrectomized eyes versus non-vitrectomized eyes with diabetic macular edema.
Wang Y, Ding Y, Zhuang Q, Luan J
Int Ophthalmol. 2024; 44(1):220.
PMID: 38713261
DOI: 10.1007/s10792-024-03136-3.
Evaluating the long-term biological stability of cytokine biomarkers in ocular fluid samples.
Felfeli T, Park J, Nestor B, Altomare F, Rai A, Mandelcorn E
BMJ Open Ophthalmol. 2023; 8(1).
PMID: 38081779
PMC: 10729172.
DOI: 10.1136/bmjophth-2023-001346.
Modified early intensive and treat-and-extend regimen of anti-vascular endothelial growth factor for diabetic macular edema in Taiwan.
Chou J, Wu J, Chen Y, Chen S
Sci Rep. 2023; 13(1):19349.
PMID: 37935742
PMC: 10630418.
DOI: 10.1038/s41598-023-43931-z.
Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders.
Hang A, Feldman S, Amin A, Ochoa J, Park S
Pharmaceuticals (Basel). 2023; 16(8).
PMID: 37631054
PMC: 10458692.
DOI: 10.3390/ph16081140.
Relationship between Diabetic Nephropathy and Development of Diabetic Macular Edema in Addition to Diabetic Retinopathy.
Suzuki Y, Kiyosawa M
Biomedicines. 2023; 11(5).
PMID: 37239172
PMC: 10216782.
DOI: 10.3390/biomedicines11051502.
Vitreous humor proteome: unraveling the molecular mechanisms underlying proliferative and neovascular vitreoretinal diseases.
Dos Santos F, Ciordia S, Mesquita J, de Sousa J, Paradela A, Tomaz C
Cell Mol Life Sci. 2022; 80(1):22.
PMID: 36585968
PMC: 11072707.
DOI: 10.1007/s00018-022-04670-y.
Preliminary Study of Different Treatment Responses between Bevacizumab, Aflibercept and Dexamethasone Implant According to Renal Function in Diabetic Macular Edema Patients.
Moon T, Jo G, Seo E, Kim K, Ku E, Kwon S
J Clin Med. 2022; 11(23).
PMID: 36498627
PMC: 9736773.
DOI: 10.3390/jcm11237047.
Review: The Development of Risk Factors and Cytokines in Retinal Vein Occlusion.
Tang Y, Cheng Y, Wang S, Wang Y, Liu P, Wu H
Front Med (Lausanne). 2022; 9:910600.
PMID: 35783660
PMC: 9240302.
DOI: 10.3389/fmed.2022.910600.
Wide-field swept-source OCT angiography of the periarterial capillary-free zone before and after anti-VEGF therapy for branch retinal vein occlusion.
Tang W, Liu W, Guo J, Zhang L, Xu G, Wang K
Eye Vis (Lond). 2022; 9(1):25.
PMID: 35778771
PMC: 9250258.
DOI: 10.1186/s40662-022-00297-z.
Upregulation of retinal VEGF and connexin 43 in murine nonarteritic anterior ischemic optic neuropathy induced with 577 nm laser.
Rangel B, Mesentier-Louro L, Lowe L, Shariati A, Dalal R, Imventarza J
Exp Eye Res. 2022; 225:109139.
PMID: 35691373
PMC: 10870834.
DOI: 10.1016/j.exer.2022.109139.
Effect of Humanin G (HNG) on inflammation in age-related macular degeneration (AMD).
Nashine S, Cohen P, Wan J, Kenney M
Aging (Albany NY). 2022; 14(10):4247-4269.
PMID: 35576057
PMC: 9186758.
DOI: 10.18632/aging.204074.
Diabetic macular ischaemia- a new therapeutic target?.
Cheung C, Fawzi A, Teo K, Fukuyama H, Sen S, Tsai W
Prog Retin Eye Res. 2021; 89:101033.
PMID: 34902545
PMC: 11268431.
DOI: 10.1016/j.preteyeres.2021.101033.
Autocrine S100B in astrocytes promotes VEGF-dependent inflammation and oxidative stress and causes impaired neuroprotection.
Ding S, Wang C, Wang W, Yu H, Chen B, Liu L
Cell Biol Toxicol. 2021; 39(5):1-25.
PMID: 34792689
DOI: 10.1007/s10565-021-09674-1.
Inflammatory mediators in diabetic retinopathy: Deriving clinicopathological correlations for potential targeted therapy.
Sheemar A, Soni D, Takkar B, Basu S, Venkatesh P
Indian J Ophthalmol. 2021; 69(11):3035-3049.
PMID: 34708739
PMC: 8725076.
DOI: 10.4103/ijo.IJO_1326_21.
Induced pluripotent stem cells can improve thrombolytic effect of low-dose rt-PA after acute carotid thrombosis in rat.
Hsieh H, Liang C, Lu C, Yang J, Chung C, Ko Y
Stem Cell Res Ther. 2021; 12(1):549.
PMID: 34674761
PMC: 8532293.
DOI: 10.1186/s13287-021-02615-z.